{"id":"sr-t100-gel","safety":{"commonSideEffects":[{"rate":null,"effect":"Local skin irritation"},{"rate":null,"effect":"Application site reactions"}]},"_chembl":{"chemblId":"CHEMBL5873720","moleculeType":null,"molecularWeight":"475.55"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"SR-T100 is derived from herbal extracts and is designed for topical application to enhance immune response and reduce inflammation in dermatological conditions. The exact molecular targets and mechanisms are proprietary to G&E Herbal Biotechnology, but the formulation is intended to work through natural bioactive compounds present in the herbal preparation.","oneSentence":"SR-T100 is a herbal-based topical gel that modulates immune and inflammatory pathways to treat skin conditions.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:36:02.952Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cutaneous T-cell lymphoma (mycosis fungoides)"},{"name":"Other dermatological conditions (Phase 3 pipeline)"}]},"trialDetails":[{"nctId":"NCT01796795","phase":"PHASE2","title":"Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients","status":"SUSPENDED","sponsor":"G&E Herbal Biotechnology Co., LTD","startDate":"2030-09","conditions":"Common Wart","enrollment":102},{"nctId":"NCT01796821","phase":"PHASE2","title":"Efficacy and Safety Profiles of SR-T100 Gel on External Genital Warts/Condyloma Acuminate(EGWs)","status":"COMPLETED","sponsor":"G&E Herbal Biotechnology Co., LTD","startDate":"2014-08","conditions":"Condyloma Acuminata, Genital Warts, Condylomata Acuminata","enrollment":138},{"nctId":"NCT02559934","phase":"PHASE1","title":"Multiple-dose Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis","status":"COMPLETED","sponsor":"G&E Herbal Biotechnology Co., LTD","startDate":"2015-11","conditions":"Actinic Keratosis","enrollment":12},{"nctId":"NCT01516515","phase":"PHASE2","title":"Efficacy and Safety Phase II Study of SR-T100 to Treat Actinic Keratosis","status":"COMPLETED","sponsor":"G&E Herbal Biotechnology Co., LTD","startDate":"2013-02","conditions":"Actinic Keratosis","enrollment":86},{"nctId":"NCT01493921","phase":"PHASE3","title":"Efficacy Study & Safety Evaluation of SR-T100 Gel in Actinic Keratosis Treatment","status":"COMPLETED","sponsor":"G&E Herbal Biotechnology Co., LTD","startDate":"2011-10","conditions":"Actinic Keratosis","enrollment":113},{"nctId":"NCT02029066","phase":"PHASE1","title":"Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis","status":"COMPLETED","sponsor":"G&E Herbal Biotechnology Co., LTD","startDate":"2013-11","conditions":"Actinic Keratosis","enrollment":2},{"nctId":"NCT01676792","phase":"EARLY_PHASE1","title":"SR-T100 Gel Efficacy & Safety Study for Vulva Pre-cancerous Lesions & Cutaneous Condyloma","status":"COMPLETED","sponsor":"National Cheng-Kung University Hospital","startDate":"2011-04","conditions":"Vulvar Intraepithelial Neoplasia, Genital Warts","enrollment":29},{"nctId":"NCT02085395","phase":"PHASE2","title":"Clinical Study Assessment of SR-T100 Topical Gel Against Actinic Keratosis","status":"COMPLETED","sponsor":"G&E Herbal Biotechnology Co., LTD","startDate":"2007-11","conditions":"Actinic Keratosis, Bowen's Disease","enrollment":27}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Solamargine","SR-T100"],"phase":"phase_3","status":"active","brandName":"SR-T100 Gel","genericName":"SR-T100 Gel","companyName":"G&E Herbal Biotechnology Co., LTD","companyId":"g-e-herbal-biotechnology-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"SR-T100 Gel is a topical treatment that has been studied for its efficacy in treating Vulvar Intraepithelial Neoplasia, Genital Warts, Actinic Keratosis, Common Wart, and Condyloma Acuminata. The gel contains 2.3% Solanum undatum plant extract, which is the active ingredient in SR-T100.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}